MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetActions
3/12/2014OppenheimerDowngradeOutperform -> Market Perform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Summer StreetBoost Price TargetBuy$10.33 -> $15.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2013OppenheimerInitiated CoverageNeutral -> Outperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2013Summer StreetInitiated CoverageBuy$10.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha